Corporate News     22-Feb-20
AstraZeneca Pharma India launches QTERN® in India
AstraZeneca Pharma India has commenced the launch of QTERN® in India. The company has already received the Import and Market Permission in Form 45 (Marketing Authorization) from the Drugs Controller General of India for FDC of Dapagliflozin 10mg + Saxagliptin 5mg film coated tablets (QTERN®).

FDC of Dapagliflozin 10mg + Saxagliptin 5mg is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus (T2DM).

Previous News
  Volumes spurt at Astrazeneca Pharma India Ltd counter
 ( Hot Pursuit - 24-Sep-24   14:30 )
  Astrazeneca Pharma India Ltd leads gainers in 'A' group
 ( Hot Pursuit - 24-Sep-24   12:00 )
  Volumes spurt at SKF India Ltd counter
 ( Hot Pursuit - 24-Sep-24   11:00 )
  Astrazenenca Pharma gets CDSCO nod to import Durvalumab solutions
 ( Hot Pursuit - 24-Sep-24   08:54 )
  AstraZeneca slumps on recording dismal Q1 performance
 ( Hot Pursuit - 08-Aug-24   16:08 )
  Astrazeneca Pharma India reports standalone net loss of Rs 11.79 crore in the June 2024 quarter
 ( Results - Announcements 08-Aug-24   15:40 )
  Astrazeneca Pharma India to hold board meeting
 ( Corporate News - 24-Jul-24   16:06 )
  Volumes jump at Borosil Renewables Ltd counter
 ( Hot Pursuit - 23-Jul-24   14:30 )
  Astrazeneca Pharma India schedules AGM
 ( Corporate News - 18-Jul-24   10:03 )
  HDFC Bank Ltd leads losers in 'A' group
 ( Hot Pursuit - 05-Jul-24   15:00 )
  Volumes soar at Astrazeneca Pharma India Ltd counter
 ( Hot Pursuit - 04-Jul-24   14:30 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top